25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIAF (bioAffinity Technologies, Inc.) Stock Analysis
Buy, Hold or Sell?

Let's analyze bioAffinity Technologies, Inc. together

I guess you are interested in bioAffinity Technologies, Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – bioAffinity Technologies, Inc.’s Financial Insights
  • 📈 Technical Analysis (TA) – bioAffinity Technologies, Inc.’s Price Targets

I'm going to help you getting a better view of bioAffinity Technologies, Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about bioAffinity Technologies, Inc.

I send you an email if I find something interesting about bioAffinity Technologies, Inc..

1. Quick Overview

1.1. Quick analysis of bioAffinity Technologies, Inc. (30 sec.)










1.2. What can you expect buying and holding a share of bioAffinity Technologies, Inc.? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
16.7%

What is your share worth?

Current worth
$0.17
Expected worth in 1 year
$-0.41
How sure are you?
16.7%

+ What do you gain per year?

Total Gains per Share
$-0.58
Return On Investment
-104.0%

For what price can you sell your share?

Current Price per Share
$0.56
Expected price per share
$0.2404 - $1.29
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of bioAffinity Technologies, Inc. (5 min.)




Live pricePrice per Share (EOD)
$0.56
Intrinsic Value Per Share
$-6.94 - $-5.17
Total Value Per Share
$-6.78 - $-5.00

2.2. Growth of bioAffinity Technologies, Inc. (5 min.)




Is bioAffinity Technologies, Inc. growing?

Current yearPrevious yearGrowGrow %
How rich?$2.6m$4.8m-$2.2m-86.6%

How much money is bioAffinity Technologies, Inc. making?

Current yearPrevious yearGrowGrow %
Making money-$9m-$7.9m-$1.1m-12.2%
Net Profit Margin-96.6%-313.4%--

How much money comes from the company's main activities?

2.3. Financial Health of bioAffinity Technologies, Inc. (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of bioAffinity Technologies, Inc.?

Welcome investor! bioAffinity Technologies, Inc.'s management wants to use your money to grow the business. In return you get a share of bioAffinity Technologies, Inc..

First you should know what it really means to hold a share of bioAffinity Technologies, Inc.. And how you can make/lose money.

Speculation

The Price per Share of bioAffinity Technologies, Inc. is $0.5601. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of bioAffinity Technologies, Inc..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in bioAffinity Technologies, Inc., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.17. Based on the TTM, the Book Value Change Per Share is $-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.40 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of bioAffinity Technologies, Inc..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.58-104.3%-0.58-104.3%-0.51-91.6%-0.50-89.3%-0.45-80.8%
Usd Book Value Change Per Share-0.15-26.0%-0.15-26.0%-0.40-71.4%0.0915.3%0.035.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.15-26.0%-0.15-26.0%-0.40-71.4%0.0915.3%0.035.0%
Usd Price Per Share0.91-0.91-1.47-0.80-0.66-
Price to Earnings Ratio-1.56--1.56--2.87--1.49--1.24-
Price-to-Total Gains Ratio-6.25--6.25--3.68--3.00--3.00-
Price to Book Ratio5.41-5.41-4.69-2.47-2.06-
Price-to-Total Gains Ratio-6.25--6.25--3.68--3.00--3.00-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.5601
Number of shares1785
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.150.09
Usd Total Gains Per Share-0.150.09
Gains per Quarter (1785 shares)-259.88153.11
Gains per Year (1785 shares)-1,039.50612.46
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1040-10500612602
20-2079-2090012251214
30-3119-3130018371826
40-4158-4170024502438
50-5198-5210030623050
60-6237-6250036753662
70-7277-7290042874274
80-8316-8330049004886
90-9356-9370055125498
100-10395-10410061246110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.06.00.00.0%0.06.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.05.00.016.7%1.05.00.016.7%
Dividend per Share0.00.01.00.0%1.00.02.033.3%1.00.04.020.0%1.00.05.016.7%1.00.05.016.7%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%1.05.00.016.7%1.05.00.016.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of bioAffinity Technologies, Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.146-0.1460%-0.400+175%0.086-270%0.028-620%
Book Value Per Share--0.1680.1680%0.314-46%-0.160+195%-0.177+205%
Current Ratio--0.8680.8680%1.767-51%2.652-67%2.232-61%
Debt To Asset Ratio--0.6010.6010%0.409+47%23.498-97%20.769-97%
Debt To Equity Ratio--1.5031.5030%0.693+117%0.460+227%0.383+292%
Dividend Per Share----0%-0%0.000-100%0.000-100%
Enterprise Value--11277366.00011277366.0000%22213613.300-49%22842872.100-51%22842872.100-51%
Eps---0.584-0.5840%-0.513-12%-0.500-14%-0.453-23%
Ev To Ebitda Ratio--infinfnan%-2.912nan%infnan%infnan%
Ev To Sales Ratio--1.2051.2050%8.771-86%2434.975-100%2434.975-100%
Free Cash Flow Per Share---0.469-0.4690%-0.392-17%-0.283-40%-0.263-44%
Free Cash Flow To Equity Per Share---0.106-0.1060%-0.414+291%0.036-393%0.028-474%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.171--------
Intrinsic Value_10Y_min---6.945--------
Intrinsic Value_1Y_max---0.334--------
Intrinsic Value_1Y_min---0.464--------
Intrinsic Value_3Y_max---1.144--------
Intrinsic Value_3Y_min---1.603--------
Intrinsic Value_5Y_max---2.124--------
Intrinsic Value_5Y_min---2.963--------
Market Cap8668443.660-62%14083706.00014083706.0000%22758340.300-38%12320921.260+14%10267434.383+37%
Net Profit Margin---0.966-0.9660%-3.134+225%-1309.185+135485%-1090.988+112887%
Operating Margin----0%-3.1110%-572.5530%-477.1270%
Operating Ratio---0.008-0.0080%4.148-100%506.740-100%422.283-100%
Pb Ratio3.331-62%5.4135.4130%4.687+15%2.468+119%2.057+163%
Pe Ratio-0.959+38%-1.558-1.5580%-2.867+84%-1.492-4%-1.244-20%
Price Per Share0.560-62%0.9100.9100%1.471-38%0.796+14%0.663+37%
Price To Free Cash Flow Ratio-1.193+38%-1.939-1.9390%-3.755+94%-2.293+18%-1.911-1%
Price To Total Gains Ratio-3.847+38%-6.250-6.2500%-3.678-41%-3.002-52%-3.002-52%
Quick Ratio--0.7230.7230%1.616-55%2.497-71%2.101-66%
Return On Assets---1.388-1.3880%-0.965-30%-11.459+726%-10.386+648%
Return On Equity---3.474-3.4740%-1.635-53%-1.169-66%-0.975-72%
Total Gains Per Share---0.146-0.1460%-0.400+175%0.086-270%0.028-620%
Usd Book Value--2602036.0002602036.0000%4855255.000-46%-2472569.600+195%-2733064.667+205%
Usd Book Value Change Per Share---0.146-0.1460%-0.400+175%0.086-270%0.028-620%
Usd Book Value Per Share--0.1680.1680%0.314-46%-0.160+195%-0.177+205%
Usd Dividend Per Share----0%-0%0.000-100%0.000-100%
Usd Enterprise Value--11277366.00011277366.0000%22213613.300-49%22842872.100-51%22842872.100-51%
Usd Eps---0.584-0.5840%-0.513-12%-0.500-14%-0.453-23%
Usd Free Cash Flow---7264795.000-7264795.0000%-6060708.000-17%-4375168.000-40%-4062905.833-44%
Usd Free Cash Flow Per Share---0.469-0.4690%-0.392-17%-0.283-40%-0.263-44%
Usd Free Cash Flow To Equity Per Share---0.106-0.1060%-0.414+291%0.036-393%0.028-474%
Usd Market Cap8668443.660-62%14083706.00014083706.0000%22758340.300-38%12320921.260+14%10267434.383+37%
Usd Price Per Share0.560-62%0.9100.9100%1.471-38%0.796+14%0.663+37%
Usd Profit---9039831.000-9039831.0000%-7937011.000-12%-7745221.000-14%-7005600.667-23%
Usd Revenue--9362022.0009362022.0000%2532499.000+270%2380126.000+293%1983438.333+372%
Usd Total Gains Per Share---0.146-0.1460%-0.400+175%0.086-270%0.028-620%
 EOD+3 -5MRQTTM+0 -0YOY+10 -255Y+12 -2510Y+13 -24

3.3 Fundamental Score

Let's check the fundamental score of bioAffinity Technologies, Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.959
Price to Book Ratio (EOD)Between0-13.331
Net Profit Margin (MRQ)Greater than0-0.966
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.723
Current Ratio (MRQ)Greater than10.868
Debt to Asset Ratio (MRQ)Less than10.601
Debt to Equity Ratio (MRQ)Less than11.503
Return on Equity (MRQ)Greater than0.15-3.474
Return on Assets (MRQ)Greater than0.05-1.388
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of bioAffinity Technologies, Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.149
Ma 20Greater thanMa 500.464
Ma 50Greater thanMa 1000.567
Ma 100Greater thanMa 2000.773
OpenGreater thanClose0.610
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About bioAffinity Technologies, Inc.

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.

Fundamental data was last updated by Penke on 2025-04-04 06:54:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit bioAffinity Technologies, Inc. earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare bioAffinity Technologies, Inc. to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -96.6% means that $-0.97 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of bioAffinity Technologies, Inc.:

  • The MRQ is -96.6%. The company is making a huge loss. -2
  • The TTM is -96.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-96.6%TTM-96.6%0.0%
TTM-96.6%YOY-313.4%+216.8%
TTM-96.6%5Y-130,918.5%+130,822.0%
5Y-130,918.5%10Y-109,098.8%-21,819.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-96.6%2.2%-98.8%
TTM-96.6%-7.4%-89.2%
YOY-313.4%2.5%-315.9%
5Y-130,918.5%-1.4%-130,917.1%
10Y-109,098.8%0.7%-109,099.5%
4.3.1.2. Return on Assets

Shows how efficient bioAffinity Technologies, Inc. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare bioAffinity Technologies, Inc. to the Diagnostics & Research industry mean.
  • -138.8% Return on Assets means that bioAffinity Technologies, Inc. generated $-1.39 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of bioAffinity Technologies, Inc.:

  • The MRQ is -138.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -138.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-138.8%TTM-138.8%0.0%
TTM-138.8%YOY-96.5%-42.2%
TTM-138.8%5Y-1,145.9%+1,007.1%
5Y-1,145.9%10Y-1,038.6%-107.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-138.8%0.5%-139.3%
TTM-138.8%-1.2%-137.6%
YOY-96.5%0.1%-96.6%
5Y-1,145.9%0.2%-1,146.1%
10Y-1,038.6%-0.1%-1,038.5%
4.3.1.3. Return on Equity

Shows how efficient bioAffinity Technologies, Inc. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare bioAffinity Technologies, Inc. to the Diagnostics & Research industry mean.
  • -347.4% Return on Equity means bioAffinity Technologies, Inc. generated $-3.47 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of bioAffinity Technologies, Inc.:

  • The MRQ is -347.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -347.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-347.4%TTM-347.4%0.0%
TTM-347.4%YOY-163.5%-183.9%
TTM-347.4%5Y-116.9%-230.5%
5Y-116.9%10Y-97.5%-19.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-347.4%1.3%-348.7%
TTM-347.4%--347.4%
YOY-163.5%0.8%-164.3%
5Y-116.9%-0.5%-116.4%
10Y-97.5%-0.9%-96.6%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of bioAffinity Technologies, Inc..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient bioAffinity Technologies, Inc. is operating .

  • Measures how much profit bioAffinity Technologies, Inc. makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare bioAffinity Technologies, Inc. to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of bioAffinity Technologies, Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-311.1%+311.1%
TTM-5Y-57,255.3%+57,255.3%
5Y-57,255.3%10Y-47,712.7%-9,542.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--11.3%+11.3%
TTM--11.1%+11.1%
YOY-311.1%2.9%-314.0%
5Y-57,255.3%3.0%-57,258.3%
10Y-47,712.7%4.8%-47,717.5%
4.3.2.2. Operating Ratio

Measures how efficient bioAffinity Technologies, Inc. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of -0.01 means that the operating costs are $-0.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of bioAffinity Technologies, Inc.:

  • The MRQ is -0.008.
  • The TTM is -0.008.
Trends
Current periodCompared to+/- 
MRQ-0.008TTM-0.0080.000
TTM-0.008YOY4.148-4.156
TTM-0.0085Y506.740-506.748
5Y506.74010Y422.283+84.457
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0081.249-1.257
TTM-0.0081.250-1.258
YOY4.1481.212+2.936
5Y506.7401.218+505.522
10Y422.2831.216+421.067
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of bioAffinity Technologies, Inc..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if bioAffinity Technologies, Inc. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.87 means the company has $0.87 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of bioAffinity Technologies, Inc.:

  • The MRQ is 0.868. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.868. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.868TTM0.8680.000
TTM0.868YOY1.767-0.899
TTM0.8685Y2.652-1.784
5Y2.65210Y2.232+0.420
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8682.384-1.516
TTM0.8682.321-1.453
YOY1.7672.397-0.630
5Y2.6522.646+0.006
10Y2.2323.047-0.815
4.4.3.2. Quick Ratio

Measures if bioAffinity Technologies, Inc. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare bioAffinity Technologies, Inc. to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.72 means the company can pay off $0.72 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of bioAffinity Technologies, Inc.:

  • The MRQ is 0.723. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.723. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.723TTM0.7230.000
TTM0.723YOY1.616-0.893
TTM0.7235Y2.497-1.774
5Y2.49710Y2.101+0.396
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7231.193-0.470
TTM0.7231.235-0.512
YOY1.6161.492+0.124
5Y2.4971.861+0.636
10Y2.1012.353-0.252
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of bioAffinity Technologies, Inc..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of bioAffinity Technologies, Inc. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare bioAffinity Technologies, Inc. to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.60 means that bioAffinity Technologies, Inc. assets are financed with 60.1% credit (debt) and the remaining percentage (100% - 60.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of bioAffinity Technologies, Inc.:

  • The MRQ is 0.601. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.601. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.601TTM0.6010.000
TTM0.601YOY0.409+0.191
TTM0.6015Y23.498-22.897
5Y23.49810Y20.769+2.729
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6010.382+0.219
TTM0.6010.436+0.165
YOY0.4090.388+0.021
5Y23.4980.425+23.073
10Y20.7690.447+20.322
4.5.4.2. Debt to Equity Ratio

Measures if bioAffinity Technologies, Inc. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare bioAffinity Technologies, Inc. to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 150.3% means that company has $1.50 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of bioAffinity Technologies, Inc.:

  • The MRQ is 1.503. The company is just able to pay all its debts with equity.
  • The TTM is 1.503. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.503TTM1.5030.000
TTM1.503YOY0.693+0.810
TTM1.5035Y0.460+1.043
5Y0.46010Y0.383+0.077
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5030.568+0.935
TTM1.5030.628+0.875
YOY0.6930.563+0.130
5Y0.4600.686-0.226
10Y0.3830.664-0.281
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings bioAffinity Technologies, Inc. generates.

  • Above 15 is considered overpriced but always compare bioAffinity Technologies, Inc. to the Diagnostics & Research industry mean.
  • A PE ratio of -1.56 means the investor is paying $-1.56 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of bioAffinity Technologies, Inc.:

  • The EOD is -0.959. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.558. Based on the earnings, the company is expensive. -2
  • The TTM is -1.558. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.959MRQ-1.558+0.599
MRQ-1.558TTM-1.5580.000
TTM-1.558YOY-2.867+1.309
TTM-1.5585Y-1.492-0.066
5Y-1.49210Y-1.244-0.249
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.9591.692-2.651
MRQ-1.5582.014-3.572
TTM-1.558-0.615-0.943
YOY-2.8674.701-7.568
5Y-1.4924.284-5.776
10Y-1.2449.331-10.575
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of bioAffinity Technologies, Inc.:

  • The EOD is -1.193. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.939. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.939. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.193MRQ-1.939+0.745
MRQ-1.939TTM-1.9390.000
TTM-1.939YOY-3.755+1.816
TTM-1.9395Y-2.293+0.354
5Y-2.29310Y-1.911-0.382
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-1.193-0.105-1.088
MRQ-1.939-0.155-1.784
TTM-1.9390.136-2.075
YOY-3.755-1.060-2.695
5Y-2.293-0.670-1.623
10Y-1.911-1.761-0.150
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of bioAffinity Technologies, Inc. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 5.41 means the investor is paying $5.41 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of bioAffinity Technologies, Inc.:

  • The EOD is 3.331. Based on the equity, the company is fair priced.
  • The MRQ is 5.413. Based on the equity, the company is overpriced. -1
  • The TTM is 5.413. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.331MRQ5.413-2.081
MRQ5.413TTM5.4130.000
TTM5.413YOY4.687+0.725
TTM5.4135Y2.468+2.944
5Y2.46810Y2.057+0.411
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.3311.672+1.659
MRQ5.4132.078+3.335
TTM5.4132.144+3.269
YOY4.6872.351+2.336
5Y2.4683.364-0.896
10Y2.0574.064-2.007
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of bioAffinity Technologies, Inc..

4.8.1. Institutions holding bioAffinity Technologies, Inc.

Institutions are holding 2.467% of the shares of bioAffinity Technologies, Inc..

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-12-31Vanguard Group Inc1.4474026086900
2024-12-31Geode Capital Management, LLC0.55240995511237014.1889
2024-12-31Sheaff Brock Investment Advisors, LLC0.25690.00374630426304131.52
2024-12-31CapTrust Financial Advisors0.15470.00012788500
2024-12-31State Street Corp0.097701760000
2024-12-31TWO SIGMA SECURITIES, LLC0.080.001714420144200
2024-12-31Northern Trust Corp0.075801366200
2024-12-31Citadel Advisors Llc0.0736013264132640
2024-12-31Creative Planning Inc0.067101209500
2024-12-31XTX Topco Ltd0.05890.000810616-648-5.7528
2024-12-31IFP Advisors, LLC0.05550.00031000000
2024-12-31Tower Research Capital LLC0.03510.000163324247203.693
2024-12-31Oarsman Capital, Inc0.01360.0004244824480
2024-12-31Morgan Stanley - Brokerage Accounts0.00280500-4461-89.9214
2024-09-30CLEAR STREET LLC.0.000601001000
2024-12-31Bank of America Corp0.00050841725.3731
2024-12-31JPMorgan Chase & Co0.0001021-21-50
2024-09-30Ground Swell Capital, LLC000-22864-100
2024-09-30UBS Group AG000-9591-100
2024-09-30Renaissance Technologies Corp000-22967-100
Total 2.97270.0071535751+12618+2.4%

4.9.2. Funds holding bioAffinity Technologies, Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-02-28Vanguard Total Stock Mkt Idx Inv1.2735022952793004.2229
2025-01-31Fidelity Extended Market Index0.25480.000145929-698-1.497
2025-02-28Vanguard Institutional Extnd Mkt Idx Tr0.225504064200
2025-01-31Fidelity Nasdaq Composite Index0.10030.00011806900
2025-01-31Fidelity Total Market Index0.07601370400
2025-01-31Fidelity Series Total Market Index0.06401154100
2024-12-31NT Ext Equity Mkt Idx Fd - NL0.05220.0001940200
2025-01-31Spartan Extended Market Index Pool E0.04510.000181206989.4045
2024-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.04130.00017452-123-1.6238
2024-12-31Northern Trust Extended Eq Market Idx0.02360.0001426000
2024-12-31NT Ext Equity Mkt Idx Fd - L0.02360.0001426000
2025-01-31Spartan Total Market Index Pool E0.01210218800
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.00560.0001101510150
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.00560.0001101510150
2024-09-30NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00360.000165710.1524
Total 2.20680.001397781+11208+2.8%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-12-312021-12-312022-12-312023-12-312024-12-31
Operating Income  -2,604398-2,207-1,804-4,011-3,962-7,97317,4109,437
Other Operating Expenses  2,604-3982,2071,8094,0166,49010,506-10,580-75
Income Tax Expense  3-12121921-33-12
Total Operating Expenses  2,604-3982,2071,8094,0154,7498,765-8,840-75



5.2. Latest Balance Sheet

Balance Sheet of 2024-12-31. All numbers in thousands.

Summary
Total Assets6,514
Total Liabilities3,912
Total Stockholder Equity2,602
 As reported
Total Liabilities 3,912
Total Stockholder Equity+ 2,602
Total Assets = 6,514

Assets

Total Assets6,514
Total Current Assets2,695
Long-term Assets3,819
Total Current Assets
Cash And Cash Equivalents 1,105
Net Receivables 1,139
Inventory 28
Other Current Assets 423
Total Current Assets  (as reported)2,695
Total Current Assets  (calculated)2,695
+/-0
Long-term Assets
Property Plant Equipment 1,619
Goodwill 1,404
Intangible Assets 775
Long-term Assets Other 20
Long-term Assets  (as reported)3,819
Long-term Assets  (calculated)3,819
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,105
Long-term Liabilities807
Total Stockholder Equity2,602
Total Current Liabilities
Short-term Debt 694
Accounts payable 987
Other Current Liabilities 1,399
Total Current Liabilities  (as reported)3,105
Total Current Liabilities  (calculated)3,081
+/- 24
Long-term Liabilities
Long-term Liabilities  (as reported)807
Long-term Liabilities  (calculated)0
+/- 807
Total Stockholder Equity
Common Stock107
Retained Earnings -53,644
Other Stockholders Equity 56,140
Total Stockholder Equity (as reported)2,602
Total Stockholder Equity (calculated)2,602
+/-0
Other
Cash and Short Term Investments 1,105
Common Stock Shares Outstanding 12,392
Current Deferred Revenue24
Liabilities and Stockholders Equity 6,514
Net Debt 396
Net Working Capital -410
Short Long Term Debt Total 1,501



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-31
> Total Assets 
659
146
1,453
12,182
8,222
6,514
6,5148,22212,1821,453146659
   > Total Current Assets 
618
119
1,438
11,962
3,973
2,695
2,6953,97311,9621,438119618
       Cash And Cash Equivalents 
578
83
1,361
11,414
2,822
1,105
1,1052,82211,4141,36183578
       Net Receivables 
2
2
2
10
812
1,139
1,13981210222
       Other Current Assets 
37
34
76
532
321
423
423321532763437
   > Long-term Assets 
41
27
15
220
4,249
3,819
3,8194,249220152741
       Property Plant Equipment 
29
9
5
214
1,995
1,619
1,6191,9952145929
       Goodwill 
0
0
0
0
1,404
1,404
1,4041,4040000
       Intangible Assets 
0
0
0
0
833
775
7758330000
       Long-term Assets Other 
13
18
10
6
16
20
20166101813
> Total Liabilities 
4,694
15,218
17,244
1,139
3,366
3,912
3,9123,3661,13917,24415,2184,694
   > Total Current Liabilities 
4,694
11,121
13,040
1,139
2,248
3,105
3,1052,2481,13913,04011,1214,694
       Short-term Debt 
4,011
9,953
11,204
252
460
694
69446025211,2049,9534,011
       Short Long Term Debt 
0
9,953
11,204
252
0
0
0025211,2049,9530
       Accounts payable 
103
191
230
345
605
987
987605345230191103
       Other Current Liabilities 
580
976
1,605
542
1,150
1,399
1,3991,1505421,605976580
   > Long-term Liabilities 
0
4,098
4,205
597
1,118
807
8071,1185974,2054,0980
       Deferred Long Term Liability 
0
0
8
0
0
0
000800
> Total Stockholder Equity
-4,036
-15,073
-15,791
11,043
4,855
2,602
2,6024,85511,043-15,791-15,073-4,036
   Common Stock
19
19
19
59
66
107
1076659191919
   Retained Earnings -53,644-44,604-36,667-28,513-22,187-14,918
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
6,838
7,095
12,704
47,652
49,394
56,140
56,14049,39447,65212,7047,0956,838



5.4. Balance Sheets

All numbers in thousands.




5.5. Cash Flows

All numbers in thousands.




5.6. Income Statements

All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue9,362
Cost of Revenue-0
Gross Profit9,3629,362
 
Operating Income (+$)
Gross Profit9,362
Operating Expense--75
Operating Income9,4379,437
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense-750
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income9,437
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-9,02827,902
EBIT - interestExpense = 0
-9,051
-9,040
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-9,028
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-9,028
Tax Provision-0
Net Income From Continuing Ops0-9,028
Net Income-9,040
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses-75
Total Other Income/Expenses Net-18,4650
 

Technical Analysis of bioAffinity Technologies, Inc.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of bioAffinity Technologies, Inc.. The general trend of bioAffinity Technologies, Inc. is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine bioAffinity Technologies, Inc.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. bioAffinity Technologies, Inc. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of bioAffinity Technologies, Inc..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.15 < 1.25 < 1.29.

The bearish price targets are: 0.26 > 0.2505 > 0.2404.

Know someone who trades $BIAF? Share this with them.👇

bioAffinity Technologies, Inc. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of bioAffinity Technologies, Inc.. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

bioAffinity Technologies, Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of bioAffinity Technologies, Inc.. The current macd is 0.04356515.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the bioAffinity Technologies, Inc. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for bioAffinity Technologies, Inc.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the bioAffinity Technologies, Inc. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
bioAffinity Technologies, Inc. Daily Moving Average Convergence/Divergence (MACD) ChartbioAffinity Technologies, Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of bioAffinity Technologies, Inc.. The current adx is 46.45.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy bioAffinity Technologies, Inc. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
bioAffinity Technologies, Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of bioAffinity Technologies, Inc.. The current sar is 0.39001498.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
bioAffinity Technologies, Inc. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of bioAffinity Technologies, Inc.. The current rsi is 51.15. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
bioAffinity Technologies, Inc. Daily Relative Strength Index (RSI) ChartbioAffinity Technologies, Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of bioAffinity Technologies, Inc.. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the bioAffinity Technologies, Inc. price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
bioAffinity Technologies, Inc. Daily Stochastic Oscillator ChartbioAffinity Technologies, Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of bioAffinity Technologies, Inc.. The current cci is 30.31.

bioAffinity Technologies, Inc. Daily Commodity Channel Index (CCI) ChartbioAffinity Technologies, Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of bioAffinity Technologies, Inc.. The current cmo is 1.18087005.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
bioAffinity Technologies, Inc. Daily Chande Momentum Oscillator (CMO) ChartbioAffinity Technologies, Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of bioAffinity Technologies, Inc.. The current willr is -75.6065924.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that bioAffinity Technologies, Inc. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
bioAffinity Technologies, Inc. Daily Williams %R ChartbioAffinity Technologies, Inc. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of bioAffinity Technologies, Inc..

bioAffinity Technologies, Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of bioAffinity Technologies, Inc.. The current atr is 0.16034544.

bioAffinity Technologies, Inc. Daily Average True Range (ATR) ChartbioAffinity Technologies, Inc. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of bioAffinity Technologies, Inc.. The current obv is 413,068,704.

bioAffinity Technologies, Inc. Daily On-Balance Volume (OBV) ChartbioAffinity Technologies, Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of bioAffinity Technologies, Inc.. The current mfi is 92.24.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
bioAffinity Technologies, Inc. Daily Money Flow Index (MFI) ChartbioAffinity Technologies, Inc. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for bioAffinity Technologies, Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-12-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-12-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-24RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-01-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-11MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-31STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

bioAffinity Technologies, Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of bioAffinity Technologies, Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.149
Ma 20Greater thanMa 500.464
Ma 50Greater thanMa 1000.567
Ma 100Greater thanMa 2000.773
OpenGreater thanClose0.610
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of bioAffinity Technologies, Inc. with someone you think should read this too:
  • Are you bullish or bearish on bioAffinity Technologies, Inc.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about bioAffinity Technologies, Inc.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about bioAffinity Technologies, Inc.

I send you an email if I find something interesting about bioAffinity Technologies, Inc..


Comments

How you think about this?

Leave a comment

Stay informed about bioAffinity Technologies, Inc..

Receive notifications about bioAffinity Technologies, Inc. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.